What is the Procedure
Dose, duration, indication of treatment Use of GLP-1 RAs was significantly associated with increased risks of gallbladder or biliary disease at higher doses (RR, 1.56
Recent clinical guidelines increasingly recommend GLP-1RAs for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or are at high cardiovascular risk, regardless of baseline hemoglobin A1c levels
Ozempic and Wegovy are manufactured by Novo Nordisk under current Good Manufacturing Practice (cGMP) standards, after investing billions of dollars in clinical trials, FDA review, and ongoing post-market safety monitoring
Protocols that protect the transition use at least 1.2 g of protein per kilogram about 0.55 g per pound plus resistance training from the start. Stable or rising strength is more informative than a single scale or body-composition reading
(PubMed) Hardwick RN, Clarke JD, Lake AD, et al